Jacobs Levy Equity Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-82,909
| Closed | -$1.26M | – | 1115 |
|
2018
Q3 | $1.26M | Buy |
82,909
+15,349
| +23% | +$233K | 0.02% | 613 |
|
2018
Q2 | $1.13M | Sell |
67,560
-20,200
| -23% | -$339K | 0.02% | 635 |
|
2018
Q1 | $1.43M | Buy |
87,760
+37,900
| +76% | +$618K | 0.02% | 553 |
|
2017
Q4 | $638K | Buy |
49,860
+27,400
| +122% | +$351K | 0.01% | 710 |
|
2017
Q3 | $276K | Buy |
+22,460
| New | +$276K | 0.01% | 804 |
|
2015
Q2 | – | Sell |
-27,500
| Closed | -$203K | – | 889 |
|
2015
Q1 | $203K | Buy |
+27,500
| New | +$203K | ﹤0.01% | 701 |
|
2014
Q3 | – | Sell |
-75,700
| Closed | -$345K | – | 949 |
|
2014
Q2 | $345K | Buy |
+75,700
| New | +$345K | 0.01% | 691 |
|
2013
Q3 | – | Sell |
-146,199
| Closed | -$664K | – | 1056 |
|
2013
Q2 | $664K | Buy |
+146,199
| New | +$664K | 0.01% | 664 |
|